332: Pfizer's new R&D head, a VC deep-dive, and a new FDA commissioner?
The Readout Loud
00:00
Navigating the FDA: Leadership Speculation and the Balance of Innovation
This chapter delves into the potential candidates for the FDA commissioner role and the challenges the agency faces in drug approval and innovation. It highlights the critical need for proper funding and staffing to support a more responsive FDA that caters to the biotech and pharmaceutical sectors.
Transcript
Play full episode
